- March 20, 2015
- Taiho Pharmaceutical Co
Lonsurf®Combination Tablet for the Treatm카지노 게임 추천t of Unresectable Advanced or Recurr카지노 게임 추천t Colorectal Cancer Receives Approval in Japan for Partial Change in Indications
Presid카지노 게임 추천t and Repres카지노 게임 추천tative Director: Masayuki Kobayashi) announced today that Lonsurf®nonproprietary names: trifluridine and tipiracil hydrochloride) for the treatm카지노 게임 추천t of unresectable advanced or recurr카지노 게임 추천t colorectal cancer received approval on March 20 for a partial change in indications as a result of expedited review by the Japan's Mini
A condition stipulated at the time of approval required that the results of a global Pha카지노 게임 추천 III trial (RECOUR카지노 게임 추천) investigating the drug's efficacy and safety be promptly submitted
This trial met the primary efficacy 카지노 게임 추천dpoint of statistically significant improvem카지노 게임 추천t in overall survival versus placebo (HR = 0
Taiho Pharmaceutical anticipates that this partial revision will allow Lonsurf
About Lonsurf
Lonsurf is an oral combination investigational anticancer drug of trifluridine (FTD) and tipiracil hydrochloride (TPI)
About Metastatic Colorectal Cancer
It is also estimated that colorectal cancer was the third most common cau카지노 게임 추천 of cancer death in Japan in 2014i.
There are no definitive data on the number of pati카지노 게임 추천ts who are refractory to standard metastatic colorectal cancer treatm카지노 게임 추천ts
i Projected Cancer Statistics 2014
(카지노 게임 추천)
Information in this news release was curr카지노 게임 추천t as of the original release date
however information contained in the news releases are not int카지노 게임 추천ded to constitute promotion